Literature DB >> 12403097

Alpha blockade in preoperative preparation of patients with pheochromocytomas.

Savas Kocak1, Semih Aydintug, Necati Canakci.   

Abstract

Preoperative preparation in pheochromocytoma is usually performed by alpha-adrenergic blockers. We retrospectively reviewed the efficiency of phenoxybenzamine, prazosin, and doxazosin in preoperative preparation. Phenoxybenzamine was used for preoperative preparation of 21 pheochromocytoma patients, prazosin was used in 11 patients, and doxazosin was used in 17 patients. Intraoperative and early postoperative blood pressure records and postoperative volume replacement records were reviewed. Intraoperative hypertension occurred in 17 patients in the phenoxybenzamine group (81%), eight patients in the prazosin group (73%), and 14 patients in the doxazosin group (82%). There was no statistical difference among the groups (P > 0.05). There was also no significant difference between postoperative blood pressure measurements and the operative and postoperative volume replacements. We have found that there were no significant difference in the operative and postoperative blood pressure and plasma volume control among the three groups. We conclude that pheochromocytoma surgery is safe with any of these preoperative medications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403097

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  21 in total

1.  Laparoscopic compared with open adrenalectomy for resection of pheochromocytoma: a review of 47 cases.

Authors:  Robert Humphrey; Daryl Gray; Stephen Pautler; Ward Davies
Journal:  Can J Surg       Date:  2008-08       Impact factor: 2.089

Review 2.  Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

3.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

Review 4.  Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Authors:  Amrish Jain; Rossana Baracco; Gaurav Kapur
Journal:  Pediatr Nephrol       Date:  2019-01-02       Impact factor: 3.714

5.  Predictors of hemodynamic instability during surgery for pheochromocytoma.

Authors:  Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2014-06-18       Impact factor: 5.344

6.  Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.

Authors:  Reese W Randle; Courtney J Balentine; Susan C Pitt; David F Schneider; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2016-08-25       Impact factor: 5.344

7.  Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.

Authors:  Ritesh Agrawal; Saroj Kanta Mishra; Eesh Bhatia; Anjali Mishra; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

8.  Pheochromocytoma in children and adolescents.

Authors:  H K Ganesh; Shrikrishna V Acharya; Joe Goerge; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2010-01-14       Impact factor: 1.967

9.  Laparoscopic adrenalectomy as an effective approach to massive bilateral pheochromocytomas.

Authors:  Diana Martins; Dírcea Rodrigues; Miguel Melo; Francisco Carrilho
Journal:  BMJ Case Rep       Date:  2017-09-07

Review 10.  Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.

Authors:  Lauren Fishbein; Robert Orlowski; Debbie Cohen
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-03-15       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.